Mohamed Gamal Thabit
PROFESSIONAL SUMMARY
- Drug Design and Synthesis.
- Molecular Modeling and Docking Simulation.
- Nuclear Magnetic Resonance (NMR) Drug Design.
- Computer Aided Drug Design.
- Modern NMR Techniques Basis and Applications in Structural Elucidation.
- Teaching Pharmaceutical Organic Chemistry, Medicinal Chemistry and Drug Design.
EXPERIENCE
Academic Experiences:
- Lecturer of Pharmaceutical Chemistry Faculty of Pharmacy-Merit University Oct. 1, 2022-present Egypt (Sohag)
Laboratory Experiences:
- Molecular Modeling Study 2010-2020 Faculty of Pharmacy-Mansoura University Egypt (Mansoura)
- Drug Design and Synthesis Study 2007-2020 Faculty of Pharmacy-Mansoura University Egypt (Mansoura)
Pharmaceutical Experiences:
- Scientific Office Head 2006 Alfa pharmaceutical company Egypt
- Research and Development (R&D) Manger 2004-2005 Hayat company KSA
- Senior Medical Representative 1997-1998 Schering-Plough corporation Egypt
- Hospital Pharmacist 1995-Dec. 1996 Airforce hospital Egypt
- Pharmacy and Private Job Owner 1997-2020 Mohamed Gamal pharmacy Egypt (Mansoura)
EDUCATION
- PhD degree in pharmaceutical science 2016-2021 Faculty of Pharmacy-Mansoura University Egypt (Mansoura)
- Master degree in pharmaceutical science 2010-2015 Faculty of Pharmacy-Mansoura University Egypt (Mansoura)
- Postgraduate diploma in drug design and synthesis 2007-2008 Faculty of Pharmacy-Mansoura University Egypt (Mansoura)
- Bachelor of Pharmacy 1990-1995 Faculty of Pharmacy-Mansoura University Egypt (Mansoura)
- Computer software utilization study 1997 AUC Egypt
PUBLICATIONS
Journals:
- G. Thabit, A. S. Mostafa, K. B. Selim, M. A. A. Elsayed and M. N. A. Nasr., Insights into Modulating the Monastrol Scaffold: Development of New Pyrimidinones as Eg5 Inhibitors with Anticancer activity, Arch. Pharm., 2022, https://doi.org/10.1002/ardp.202200029.
- G. Thabit, A. S. Mostafa, K. B. Selim, M. A. A. Elsayed, M. N. A. Nasr, Design, Synthesis and Molecular Modeling of Phenyl Dihydropyridazinone Derivatives as B-Raf Inhibitors with Anticancer Activity, Bioorganic Chemistry, 2020, 103 (10)4148. https://doi.org/10.1016/j.bioorg.2020.104148.
- G. Thabit, S. A. El Bialy and M. N. A. Nasr, Synthesis and biological evaluation of new 3-(4-substituted phenyl) aminoquinoxaline derivatives as anticancer agents, Heterocyclic Communications, 2015, 21, 25–35. https://doi.org/10.1515/hc-2014-0081.
Scientific Conferences:
Oral presentation
- Insights into Modulation of Monastrol Scaffold: Design and Synthesis of New Pyrimidinones as Eg5 Inhibitors with Anticancer activity, Mohamed G. Thabit, Amany S. Mostafa, Khalid B. Selim, Magda A. Elsayed and Magda N. A. Nasr., 4th Hybrid Scientific Conference of Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Mansoura University Sept. 7 & 11, 2021.
Abstract, Proceeding and Poster
- Synthesis and Anticancer Evaluation of New Dihydropyridazinone Derivatives., Mohamed G. Thabit, Amany S. Mostafa, Khalid B. Selim, Magda A. El-sayed and Magda N. A. Nasr, Second International Conference of Pharmaceutical Sciences (MU-PHARM 2019), Mansoura University & Ein- Sokhna, April 21-23, 2019.
- Design, Synthesis and Structural Elucidation of pyridazinone derivatives as antitumor agents, Mohamed G. Thabit, Amany S. Mostafa, Khalid B. Selim, Magda A. El-sayed and Magda N. A. Nasr, First International Conference of Pharmaceutical Sciences (MU-PHARM 2017), Mansoura University, April 9-11, 2017.
Trainer
- Computer aided drug design, faculty of pharmacy, Univ. (Feb. 7-8, 2010).